Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Molecular Cancer Therapeutics|May 21, 2013
Polo-like kinase inhibitor Ro5203280 has potent antitumor activity in nasopharyngeal carcinomaArthur Kwok Leung Cheung, Joseph Chok Yan Ip, Hong Lok Lung, et al.Cancers|April 13, 2023
THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC ActivationLuo Chen, Wai Yin Chau, Hei Tung Yuen, et al.Frontiers in Oncology|June 13, 2020
Targeting Epstein-Barr Virus in Nasopharyngeal CarcinomaPok Man Hau, Hong Lok Lung, Man Wu, et al.Nanoscale|August 10, 2018
Responsive upconversion nanoprobe for monitoring and inhibition of EBV-associated cancers via targeting EBNA1Shuai Zha, Yan Ho Fung, Ho-Fai Chau, et al.Cancers|July 9, 2022
The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal CarcinomaLuo Chen, Yiu Chun Chiang, Lai Sheung Chan, et al.Scientific Reports|August 21, 2019
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cellsHong Lok Lung, Rebecca Kan, Wai Yin Chau, et al.Journal of Experimental & Clinical Cancer Research : CR|January 16, 2019
SOX9 is a dose-dependent metastatic fate determinant in melanomaXintao Yang, Rui Liang, Chunxi Liu, et al.International Journal of Cancer|August 25, 2006
Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinomaWing Lung Yau, Hong Lok Lung, Eugene R Zabarovsky, et al.Advanced Healthcare Materials|July 24, 2025
Development of a Modular Ribonucleoprotein Complex as a General Strategy to Deliver RNAi TherapeuticsNok Yin Tam, Xiaoqi Wang, Grace Chung Yan Chan, et al.International Journal of Cancer|September 24, 2004
Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinomaHong Lok Lung, Yue Cheng, Mande Kuppusamy Kumaran, et al.Pageof 5